Autoantibodies to glutamic acid decarboxylase in patients with epilepsy are associated with low cortical GABA levels.
Antibodies to glutamic acid decarboxylase (GAD), the major pathway for the synthesis of c-aminobutyric acid(GABA) in humans, are found at elevated levels in a subgroup of patients with chronic epilepsy. To test whether the antibodies were associated with changes in cortical GABA levels we used magne...
Κύριοι συγγραφείς: | Stagg, C, Lang, B, Best, J, McKnight, K, Cavey, A, Johansen-Berg, H, Vincent, A, Palace, J |
---|---|
Μορφή: | Journal article |
Γλώσσα: | English |
Έκδοση: |
2010
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
SERUM AUTOANTIBODIES TO GLUTAMIC ACID DECARBOXYLASE ARE ASSOCIATED WITH REDUCED CORTICAL GABA LEVELS IN PATIENTS WITH EPILEPSY
ανά: Stagg, C, κ.ά.
Έκδοση: (2009) -
The role of anti-glutamic acid decarboxylase autoantibodies (GAD-Ab) in idiopathic late onset cerebellar ataxia (ILOCA)
ανά: Muzaimi, M, κ.ά.
Έκδοση: (2004) -
Glutamic Acid Decarboxylase Autoantibodies-Related Encephalitis
ανά: J Gordon Millichap
Έκδοση: (2011-09-01) -
Autoantibodies as a cause of epilepsy
ανά: Wroe, S, κ.ά.
Έκδοση: (2003) -
Serum antibodies in patients with epilepsy
ανά: Lang, B, κ.ά.
Έκδοση: (2005)